bims-tuinlyTumor-infiltrating lymphocytes therapy
This report is maintained by Pierpaolo Ginefra, Ludwig Institute for Cancer Research. It brings out roughly 9 papers per issue.
0000‒00‒00
 Sign up
2024–12–15
2024–12–08
0000‒00‒00
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
2024–12–01
2024–11–24
2024–11–17
2024–11–10
2024–11–03
2024–10–27
2024–10–20
2024–10–13
2024–10–06
2024–09–29
Pierpaolo Ginefra also maintains a report bims-imseme on “Immunosenescence and T cell metabolism”.
Here are the seven most related reports.
 1. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-flamet“Cytokines and immunometabolism in metastasis”, ∼ 27 p.p.i. ∼ 27 papers per issue
 2. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-imseme“Immunosenescence and T cell metabolism”, ∼ 13 p.p.i. ∼ 13 papers per issue
 3. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-tumhet“Tumor Heterogeneity”, ∼ 7 p.p.i. ∼ 7 papers per issue
 4. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-stacyt“Metabolism and the paracrine crosstalk between cancer and the organism”, ∼ 6 p.p.i. ∼ 6 papers per issue
 5. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-meluca“Metabolism of non-small cell lung carcinoma”, ∼ 9 p.p.i. ∼ 9 papers per issue
 6. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-instec“Intestinal stem cells and chemoresistance in colon cancer and intestinal regeneration”, ∼ 12 p.p.i. ∼ 12 papers per issue
 7. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-cepepe“Cell-penetrating peptides”, ∼ 14 p.p.i. ∼ 14 papers per issue
This page is being maintained by Thomas Krichel. It was last updated on 2024‒12‒15 at 6:55.